India's Sun Pharma to buy US-listed Organon in about $11.8 billion deal - Reuters
India's Sun Pharma to buy US-listed Organon in about $11.8 billion deal Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"Organon's portfolio, capabilities and global reach are highly complementary to our own, and we believe that bringing the two organizations together can create a stronger and more diversified platform."
— Dilip Shanghvi , Executive
"This transaction represents a significant opportunity for Sun Pharma. Organon’s portfolio, capabilities and global reach are highly complementary to our own."
— Dilip Shanghvi , Executive
"Organon’s portfolio, capabilities and global reach are highly complementary to our own, and we believe that bringing the two organisations together can create a stronger and more diversified platform."
— Dilip Shanghvi , Executive
"Organon’s portfolio, capabilities and global reach are highly complementary to our own, and we believe that bringing the two organizations together can create a stronger and more diversified platform."
— Dilip Shanghvi , Executive
Key People
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOT0Y4NFc5aDZpdXQxOFJuZmRGaGF3NE5hSnQ3bEIxNy1WQ2J4LVVRY3JVWHBOMGxiZGRzNlFKOUxReVFvTnBJSkJJRkhkd3laS1BEaEg4Q190X3pSYkp5b3Y4RXo3RlZqVTlZcUdnYVFXMTMzaFpoc3FwckliTkUzeUdNV054cHNKb3dFNjlzX1g2S2JRNHFwRFR4U0dEQm1qb0ZZa3V0T0c2eHA3REQtWkVDZGdXLW5EUHdLdnJ3?oc=5" target="_blank">India's Sun Pharma to buy US-listed Organon in about $11.8 billion deal</a> <font color="#6f6f6f">Reuters</font>
Sun Pharmaceutical Industries has agreed to acquire Organon & Co in an all-cash deal valued at approximately $11.75 billion, with Organon shareholders set to receive $14.00 per share.
Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women’s health-care company Organon & Co., in what is likely to be one of the biggest India outbound deals in years.
Sun Pharmaceutical Industries Ltd. has agreed to acquire New York-listed women’s health-care company Organon & Co., expanding its global reach with one of the biggest outbound deals by an Indian company.
Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy Organon & Co. in a transaction valuing the New York-listed healthcare company at $11.8 billion.
Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal, valuing the US drugmaker at about US$11.75 billion including debt, in one of India’s biggest outbound deals.
Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal, valuing the U.S. drugmaker at about $11.75 billion, including debt.
Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal, valuing the US drugmaker at about $11.75 billion including debt, in one of India's biggest outbound deals.
Sun Pharmaceutical Industries has agreed to acquire U.S. drugmaker Organon & Co in an all-cash deal valued at approximately $11.75 billion, including debt.
Similar Stories
Related coverage based on topic and tags
Indian police detain 'cockroach' movement founder Abhijeet Dipke - Reuters
Indian police detain 'cockroach' movement founder Abhijeet Dipke Reuters
October 10, 2026 at 05:27 AMIndia unveils tough curbs on dollar demand to defend rupee - Reuters
India unveils tough curbs on dollar demand to defend rupee Reuters
October 10, 2026 at 03:34 AMUS says Chinese actions off Taiwan are 'deeply destabilising' - Reuters
US says Chinese actions off Taiwan are 'deeply destabilising' Reuters
October 10, 2026 at 01:10 AMIndia detains protesters, locks down Delhi ahead of rally against election chief - Reuters
India detains protesters, locks down Delhi ahead of rally against election chief Reuters
October 10, 2026 at 12:33 AMThousands of security personnel deployed as Delhi braces for ‘cockroach’ protest
Several trains to Delhi have been cancelled and dozens of metro stations are shut to stop protesters from gathering.
October 9, 2026 at 11:02 PMBoots has a new owner: Three ways it could affect you
The stalwart of Britain's High Street has been sold to a Canadian billionaire family. What will that mean for you?
October 9, 2026 at 11:01 PM